ArticlebioRxiv : the preprint server for biology2021

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.

Adi Idris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.